The FDA has acknowledged reports linking Ozempic and other GLP-1 medications to delayed gastric emptying and ileus, but critics say the label still omits full warnings of the risks
For adults whose insurance doesn't cover GLP-1 medications or who face prior authorization hurdles with brand-name products the compounded model with disclosed flat-rate monthly pricing offers a different access pathway worth understanding and discussing with a clinician
The results of this trial have not been published in the medical literature yet, so they should be assessed with caution
"We've already seen a strong reaction from insurance companies, especially when it comes to the health insurance you get through your employer," he says
#GLP1 #CKM #SDTfatty #PreclinicalModel #DiabeticKidneyDisease #Autophagy #TranslationalResearch #CLEAJapan To view or add a comment, sign in 491 followers
This international presence reflects the product's acceptance by quality-conscious manufacturers worldwide and Hongda's ability to meet diverse regulatory requirements across different jurisdictions